Email this article Features of cellularcomponent of a system inflammationin patients withmoderate and mildform of ñhronicobstructive pulmonarydisease (COPD) in acute stage
- Authors: Enikeev OA1, Enikeev OA1
-
Affiliations:
- Issue: Vol 12, No 1-2 (2012)
- Pages: 87-90
- Section: Articles
- URL: https://aspvestnik.ru/2410-3764/article/view/25495
- DOI: https://doi.org/10.17816/2072-2354.2012.0.1-2.87-90
- ID: 25495
Cite item
Full Text
Abstract
In this article we cite data which demonstrate cellular component of a system inflammation
in patients with moderate and mild stage of ñhronic obstructive pulmonary disease (COPD)
in dynamics of hospital therapy during the exacerbation of the given disease. Control group
consist from 20 conditionally healthy faces. The received results demonstrate that COPD exacerbations
in patients with moderate and mild stage is characterized by strengthening phagocytic
activity against decrease in number of such cells. Also at such patients activation Ò and B
cells, against the raised level of the T-NK-cells that depict presence of chronic inflammation
at patients already with mild stage is observed. At patients of moderate stage the exhaustion
of NK-cells is observed. It speaks about easing of antiviral and antineoplastic immunity.
in patients with moderate and mild stage of ñhronic obstructive pulmonary disease (COPD)
in dynamics of hospital therapy during the exacerbation of the given disease. Control group
consist from 20 conditionally healthy faces. The received results demonstrate that COPD exacerbations
in patients with moderate and mild stage is characterized by strengthening phagocytic
activity against decrease in number of such cells. Also at such patients activation Ò and B
cells, against the raised level of the T-NK-cells that depict presence of chronic inflammation
at patients already with mild stage is observed. At patients of moderate stage the exhaustion
of NK-cells is observed. It speaks about easing of antiviral and antineoplastic immunity.
References
- Чучалин А. Г. Хронические обструктивные болезни легких. - М., 1998. - С. 11-26.
- Лещенко И. В. Основные направления лечения хронической обструктивной болезни легких // Терапевтический архив. 2007. - № 8. - С. 75-84.
- Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2010.
- Tkacova R. Systemic inflammation in chronic obstructive pulmonary disease: may adipose tissue play a role? Review of the literature and future perspectives. Mediators Inflamm. 2010;2010:585989. Epub 2010 Apr 20.
- Wouters EF, Creutzberg EC, Schols AM. Systemic effects in COPD. Chest. 2002 May;121(5 Suppl):127S-130S.
- Similowski T, Agusti A, MacNee W. et al. The potential impact of anaemia of chronic disease in COPD. Eur Respir J. 2006 Feb;27(2):390-6.
- Gan WQ, Man SF, Senthilselvan A. et al. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2004 Jul;59(7):574-80.
- Авдеев С. Н. Хроническая обструктивная болезнь легких: Караманное руководство для практических врачей. 2-е изд., перераб. И доп. - М.: Издательский холдинг «Атмосфера», 2010-. С.17.
- Основы законодательства Российской Федерации об охране здоровья граждан: федер. Закон Рос. Федерации от 22 июля 1993 г. № 5487-1: утв. ВС РФ (ред. от 18.07.2011) // Ведомости СНД и ВС РФ", 19.08.1993, № 33, ст. 1318.
- Шубич М. Г., Медников В. Г. NBT-тест у детей в норме и при гнойно-бактериальных инфекциях. Лаб. Дело. 1978; 9: 515-518.
- Кост Е. А., Стенко М. И-. Советский грамицидин и его применение в клинической практике. Лабораторные исследования и оценка их результатов. В кн.: Научные труды клинической больницы им-. С. П. Боткина. М.; 1947. - С. 253-256.
- Аллергология и иммунология: национальное руководство / Под ред. Р. М. Хаитова, Н. И. Ильиной. - М.: ГЭОТАР-Медиа, 2009. - С.31.
- Leung B, Harris HW. NKT cells in sepsis. Clin Dev Immunol. 2010;2010. pii: 414650. Epub 2010 Oct 4.
- Kim EY, Battaile JT, Patel AC. et al. Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat Med. 2008 Jun;14(6):633-40.
Supplementary files
